Scinovex
article Open Access

Analgesic efficacy of intraperitoneal vs intravenous dexmedetomidine as adjuvant to levobupivacaine 0.25% in laparoscopic cholecystectomy under general Anaesthesia

International Journal of Medical Anesthesiology · 2020 · Vol. 3(1) · pp. 255–260
Arjun ThakurCharu SharmaBijenderAditi AditiDeepak DeepakShelly Rana

Abstract

Results: VAS score was significantly lower in dexmedetomidine group D, BD from 1hr to 8hr. From 8 hr to 24 hr, VAS score in group IV dexmedetomidine was significantly less than the other groups (P=0.01). In the postoperative period, sedation scores were more in IV dexmedetomidine group as compared to other groups till 4 hrs. The requirement of rescue analgesia in IV dexmedetomidine + IP levobupivacaine was significantly less from zero hrs to 8 hrs. Conclusion: Low bolus dose of IV dexmedetomidine is more efficacious as compared to IP dexmedetomidine (0.5 µg/kg) along with IP bupivacaine in laparoscopic cholecystectomy.

Anesthesia and Pain ManagementAnesthesia and Sedative AgentsNausea and vomiting managementDexmedetomidineMedicineLevobupivacaineAnesthesiaSedationAnalgesicSalineCholecystectomyLoading doseSurgery
Citations
1
FWCI
0.20
field-weighted impact
References
1
Percentile
51%
vs. same field & year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Analgesic efficacy of intraperitoneal vs intravenous dexmedetomidine as adjuvant to levobupivacaine 0.25% in laparoscopic cholecystectomy under general Anaesthesia · Scinovex